Navigation Links
Cancer Drug May Offer New Hope for Lupus Patients
Date:3/13/2009

Small U.K. study says Rituxan could become 1st new drug for disease in 50 years

FRIDAY, March 13 (HealthDay News) -- The cancer drug Rituxan may offer the first new treatment approved for lupus in 50 years, suggests a small study by U.K. researchers at Imperial College London.

The 22-month study included 20 people with lupus nephritis, a severe kidney disorder caused by the disease lupus. After treatment with Rituxan, 60 percent showed significant signs of improvement, the researchers found. But the drug was not effective in people of African ancestry or in those with very low levels of albumin protein in their blood.

Rituxan targets hyperactive B cells, which contribute to kidney inflammation in people with lupus. If these study results can be repeated in larger trials, Rituxan might be approved to treat lupus, the researchers said.

"This is very welcome news to the 40 percent of lupus patients who are suffering with kidney involvement in their battle with systemic lupus erythematosus, an autoimmune disease, and who until now had very little hope of a breakthrough for lupus nephritis," Virginia T. Ladd, president and executive director of the American Autoimmune Related Diseases Association, said in an association news release.

People with lupus experience a wide range of problems, including muscle pain, extreme fatigue and inflammation of the joints, skin, major organs and central nervous system.

More information

The Lupus Foundation of America has more about lupus.



-- Robert Preidt



SOURCE: American Autoimmune Related Diseases Association, news release, March 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug May Offer New Hope for Lupus Patients
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Ross ... (UCF) College of Medicine as Assistant Professor of Plastic Surgery. This is Dr. ... Clevens has worked closely with the university, developing a strong presence and a valuable ...
(Date:7/30/2015)... ... July 30, 2015 , ... Using the latest online digital technologies, happiness expert ... ways to prevent and manage major depression. , “Suicide is 100% preventable. The problem ... through the cracks and die needlessly everyday,” says Walker. “I’m out to end suicide. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 HIV infection rates rose ... on June 17th. Those untreated heroin use disorders share their needles and spread ... dirty needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to 23 ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association ... Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th ... 10:00 AM to 2:00 PM local time. On the 26th, the DEA, with ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor service ... personal-care device that makes it easy to apply lotion or medication to a hard-to-reach ... assistance when applying lotion or medication to the back, and provides thorough coverage. The ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... ROCHESTER, Minn. A new study led by researchers ... institutions has found that patients with non-Hodgkin,s lymphoma who ... diagnosis had poorer overall survival, compared to patients who ... after accounting for clinical and demographic factors, and also ...
... known by its brand name Celebrex, can help prevent the ... and small intestine of children with an inheritable genetic disease ... but devastating disease, polyps begin forming in patients as young ... or even thousands. The disease carries a 100-percent lifetime ...
... males tying the knot with younger females, study found , THURSDAY, ... nine years their junior could be upping their odds of dying ... younger guy raises a woman,s risk of death by 20 percent, ... Demography . , Not that marrying much older men is ...
... ... unveil the Center for Biotechnology Education on Thursday, May 13, at its fifth ... County campus, 9601 Medical Center Drive in Rockville. , ... (PRWEB) May 13, 2010 -- The Johns Hopkins University’s Zanvyl ...
... ... owners have been scratching their heads trying to understand the new EPA “Lead-Based Paint ... , ... 13, 2010 -- MT2, LLC of Arvada, CO is providing eco-protective green technology to ...
... The Wistar Institute offer a new explanation for the persistent ... why melanoma remains the deadliest form of skin cancer. The ... melanoma cells behave like both conventional tumor cells and cancer ... issue of the journal Cell thatcontrary to other ...
Cached Medicine News:Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 2Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 3Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 4Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 3Health News:Contractors Discover Relief from New EPA LBP RRP Rule 2Health News:Contractors Discover Relief from New EPA LBP RRP Rule 3Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 2Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 3
(Date:7/29/2015)...  Astellas today announced topline results from the ... safety of intravenous (IV) and oral isavuconazole, commercially ... adults with candidemia and other invasive Candida ... the trial did not meet its primary endpoint ... patients at the end of IV therapy compared ...
(Date:7/29/2015)... 29, 2015  Unilife Corporation ("Unilife" or the "Company") ... manufacturer and supplier of injectable drug delivery systems, today ... provides the Company with flexibility and control to support ... signed an equity purchase agreement for up to $45 ... Chicago -based institutional investor, which provides ...
(Date:7/29/2015)... , July 29, 2015  According to data ... Services, the 2016 average monthly Medicare Part D premium ... far lower than was originally projected, the Pharmaceutical Care ... D program continues to be a bright spot in ... choices in each region and using cutting edge, cost-saving ...
Breaking Medicine Technology:Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Retics is a 5-part differential control that ... Abbott CELL-DYN 3200, 3500, 3700 and 4000 ... nucleated red blood cells that can be ... The assay contains automated and manual reticulocyte ...
... hematology control for the Abbott CELL-DYN 3000, ... for the five-part white cell differential, as ... CELL-DYN 1600 and 1700. Open-vial stability is ... days. Para 12 Plus is packaged in ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
Medicine Products: